Barclays
ADMS

Barclays’s Adamas Pharmaceuticals ADMS Stock Holding History

Barclays’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100,000
Closed -$2.58M – 7537
2018
Q2 		$2.58M Buy
+100,000
New +$2.77M ﹤0.01% 2325

Barclays's ADMS Position: Q4 2021 in Review

Barclays sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 11,279 shares — an estimated $56K sold.

Barclays first reported a position in ADMS in Q2 2014 and held it in 28 quarters. The position peaked at $2.23M in Q2 2018. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

  • Barclays reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Barclays sold 11,279 Adamas Pharmaceuticals shares in Q4 2021, an estimated $56K.
  • Barclays first reported a position in Adamas Pharmaceuticals in Q2 2014 and held it in 28 quarters.
  • Barclays's Adamas Pharmaceuticals position peaked at $2.23M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.